Nguyen, T. H. T., Pham, X. D., Dao, K. L., & Vo, T. T. (2021). Response to a Combination of Full-Dose Osimertinib and Ceritinib in a Non-Small Cell Lung Cancer Patient with EML4-ALK Rearrangement and Epidermal Growth Factor Receptor Co-Mutation. Case Rep Oncol.
Chicago ZitierstilNguyen, Thai Hoa Thi, Xuan Dung Pham, Khanh Linh Dao, und Thanh Toan Vo. "Response to a Combination of Full-Dose Osimertinib and Ceritinib in a Non-Small Cell Lung Cancer Patient With EML4-ALK Rearrangement and Epidermal Growth Factor Receptor Co-Mutation." Case Rep Oncol 2021.
MLA ZitierstilNguyen, Thai Hoa Thi, Xuan Dung Pham, Khanh Linh Dao, und Thanh Toan Vo. "Response to a Combination of Full-Dose Osimertinib and Ceritinib in a Non-Small Cell Lung Cancer Patient With EML4-ALK Rearrangement and Epidermal Growth Factor Receptor Co-Mutation." Case Rep Oncol 2021.